| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ae95c644a70b2623afed7674ff7afe6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-736 |
| filingDate |
2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c196ee8e84b5ebfca3212b64d5210db |
| publicationDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011226992-B2 |
| titleOfInvention |
Immunostimulatory and vaccine compositions |
| abstract |
The present invention provides an immunostimulatory composition comprising mannans, wherein at least 75% of the mannans are greater than about 1000 kDa and/or have at least 150 aldehyde groups. The present invention also provides for the use of this composition in vaccination and gene therapy methods, together with processes for its preparation. |
| priorityDate |
2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |